Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 Phase III study design. Supplementary Material
figure
posted on 2022-01-26, 10:22 authored by Neeraj Agarwal, Arun Azad, Neal D. Shore, Joan Carles, André P. Fay, Curtis Dunshee, Lawrence Ivan Karsh, Maria Luisa Paccagnella, Nicola Di Santo, Mohamed Elmeliegy, Xun Lin, Akos Czibere, Karim Fizazi|
Supplementary Figure 1- Study locations of TALAPRO-2
Supplementary Methods - DDR alteration analysis
Infographic – Summary of the TALAPRO-2 study |
